Armistice Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-378,000
| Closed | -$14.6M | – | 224 |
|
|
2025
Q1 | $14.6M | Sell |
378,000
-2,000,000
| -84% | -$77.5M | 0.22% | 76 |
|
|
2024
Q4 | $80.4M | Buy |
2,378,000
+1,854,000
| +354% | +$62.7M | 1.1% | 10 |
|
|
2024
Q3 | $21.4M | Sell |
524,000
-976,000
| -65% | -$39.9M | 0.34% | 49 |
|
|
2024
Q2 | $57.8M | Buy |
1,500,000
+536,000
| +56% | +$20.6M | 0.73% | 16 |
|
|
2024
Q1 | $41.3M | Sell |
964,000
-1,232,000
| -56% | -$52.8M | 0.55% | 31 |
|
|
2023
Q4 | $81.4M | Buy |
2,196,000
+1,911,000
| +671% | +$70.8M | 1.11% | 7 |
|
|
2023
Q3 | $10.3M | Sell |
285,000
-15,000
| -5% | -$544K | 0.16% | 83 |
|
|
2023
Q2 | $10.7M | Sell |
300,000
-2,936,000
| -91% | -$105M | 0.15% | 88 |
|
|
2023
Q1 | $115M | Buy |
3,236,000
+180,000
| +6% | +$6.4M | 1.66% | 8 |
|
|
2022
Q4 | $107M | Sell |
3,056,000
-544,000
| -15% | -$19.1M | 1.87% | 9 |
|
|
2022
Q3 | $106M | Buy |
+3,600,000
| New | +$106M | 1.84% | 9 |
|
|
2018
Q1 | – | Sell |
-329,600
| Closed | -$14.6M | – | 69 |
|
|
2017
Q4 | $14.6M | Buy |
+329,600
| New | +$14.6M | 1.46% | 20 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 36 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 38 |
|